Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihiro Fujiya is active.

Publication


Featured researches published by Yoshihiro Fujiya.


Emerging Infectious Diseases | 2015

Autochthonous dengue fever, Tokyo, Japan, 2014.

Satoshi Kutsuna; Yasuyuki Kato; Meng Ling Moi; Akira Kotaki; Masayuki Ota; Koh Shinohara; Tetsuro Kobayashi; Kei Yamamoto; Yoshihiro Fujiya; Momoko Mawatari; Tastuya Sato; Junwa Kunimatsu; Nozomi Takeshita; Kayoko Hayakawa; Shuzo Kanagawa; Tomohiko Takasaki; Norio Ohmagari

After 70 years with no confirmed autochthonous cases of dengue fever in Japan, 19 cases were reported during August–September 2014. Dengue virus serotype 1 was detected in 18 patients. Phylogenetic analysis of the envelope protein genome sequence from 3 patients revealed 100% identity with the strain from the first patient (2014) in Japan.


Journal of Travel Medicine | 2016

Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urines.

Koh Shinohara; Satoshi Kutsuna; Tomohiko Takasaki; Meng Ling Moi; Makiko Ikeda; Akira Kotaki; Kei Yamamoto; Yoshihiro Fujiya; Momoko Mawatari; Nozomi Takeshita; Kayoko Hayakawa; Shuzo Kanagawa; Yasuyuki Kato; Norio Ohmagari

In July 2014, a Japanese traveller returning from Thailand was investigated for fever, headache, rash and conjunctivitis. Zika virus RNA was detected in his urine sample by real-time reverse transcription polymerase chain reaction. Serological tests showed cross reactivity of IgM against the dengue virus. Zika fever could be misdiagnosed or missed and should be considered in febrile patients with a rash, especially those returning from Thailand.


Journal of Infection and Chemotherapy | 2015

Comparison of clinical characteristics and laboratory findings of malaria, dengue, and enteric fever in returning travelers: 8-year experience at a referral center in Tokyo, Japan

Satoshi Kutsuna; Kayoko Hayakawa; Yasuyuki Kato; Yoshihiro Fujiya; Momoko Mawatari; Nozomi Takeshita; Shuzo Kanagawa; Norio Ohmagari

BACKGROUND Without specific symptoms, diagnosis of febrile illness in returning travelers is challenging. Dengue, malaria, and enteric fever are common causes of fever in returning travelers and timely and appropriate treatment is important. However, differentiation is difficult without specific diagnostic tests. METHODS A retrospective study was conducted at the National Centre for Global Health and Medicine (NCGM) from April 2005 to March 2013. Febrile travelers returning from overseas who were diagnosed with dengue, malaria, or enteric fever were included in this study. Clinical characteristics and laboratory findings were compared for each diagnosis. RESULTS During the study period, 86 malaria, 85 dengue, and 31 enteric fever cases were identified. The mean age of the study cohort was 33.1 ± 12 years and 134 (66.3%) study participants were male. Asia was the most common area visited by returning travelers with fevers (89% of dengue, 18.6% of malaria, and 100% of enteric fever cases), followed by Africa (1.2% of dengue and 70.9% of malaria cases). Clinical characteristics and laboratory findings were significantly different among each group with each diagnosis. Decision tree models revealed that returning from Africa and CRP levels <10 mg/L were factors specific for diagnosis of malaria and dengue fever, respectively. CONCLUSION Clinical manifestations, simple laboratory test results, and regions of travel are helpful to distinguish between dengue, malaria, and enteric fever in febrile returning travelers with non-specific symptoms.


Journal of Infection and Chemotherapy | 2015

Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei

Masayoshi Tojo; Momoko Mawatari; Kayoko Hayakawa; Maki Nagamatsu; Kayo Shimada; Kazuhisa Mezaki; Yuko Sugiki; Emi Kuroda; Nozomi Takeshita; Satoshi Kutsuna; Yoshihiro Fujiya; Tohru Miyoshi-Akiyama; Teruo Kirikae; Norio Ohmagari

We report a case of multidrug-resistant (MDR) Acinetobactor baumannii isolates obtained from a traveler returned from Brunei. Whole-genome sequencing analysis revealed that the isolates harbored blaOxA-23 and armA. The minimum inhibitory concentrations of antibiotics against the strain were as follows: imipenem, 32 μg/ml; meropenem, 32 μg/ml; ciprofloxacin, 16 μg/ml; amikacin, ≧ 1024 μg/ml; arbekacin, ≧ 1024 μg/ml; aztreonam, 64 μg/ml; colistin, 4 μg/ml. A. baumannii harboring both blaOxA-23 and armA is rarely reported in Japan, and, to the best of our knowledge, this is the second report of A. baumannii harboring both resistant genes in Japan.


Journal of Infection and Chemotherapy | 2017

Epidemiology of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in Japan: Characteristics of community-associated versus healthcare-associated ESBL E. coli

Kayoko Hayakawa; Maki Nagamatsu; Kazuhisa Mezaki; Yuko Sugiki; Satoshi Kutsuna; Nozomi Takeshita; Kei Yamamoto; Momoko Mawatari; Yoshihiro Fujiya; Norio Ohmagari

Data on community-associated extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (CA-ESBLEC) infections in Japan are scarce. We compared the clinical and microbiological epidemiology of CA-ESBLEC infections with that of healthcare-associated-ESBLEC infections among 76 patients with ESBLEC infections. We identified a high prevalence (26%) of CA-ESBLEC infections in Japan; only a small proportion (15%) of patients with CA-ESBLEC infections had recent exposure to antibiotics.


Internal Medicine | 2015

Two Cases of Granulomatous Mastitis Caused by Corynebacterium kroppenstedtii Infection in Nulliparous Young Women with Hyperprolactinemia.

Satoshi Kutsuna; Kazuhisa Mezaki; Maki Nagamatsu; Junwa Kunimatsu; Kei Yamamoto; Yoshihiro Fujiya; Momoko Mawatari; Nozomi Takeshita; Kayoko Hayakawa; Yasuyuki Kato; Shuzo Kanagawa; Norio Ohmagari

Recently, an association between granulomatous mastitis and local infection with Corynebacterium (C.) kroppenstedtii has been suggested. We herein report two cases of granulomatous mastitis resulting from C. kroppenstedtii infection in nulliparous young women with hyperprolactinemia. Both cases involved nulliparous patients with drug-induced hyperprolactinemia, and both individuals received incision and drainage, after which the pus was sent to our laboratory. Corynebacterium spp. grew on blood agar, and 16S rRNA gene sequencing identified the pathogen as C. kroppenstedtii. In conclusion, lactational changes caused by drug-induced hyperprolactinemia may increase the risk of granulomatous mastitis after C. kroppenstedtii infection.


American Journal of Tropical Medicine and Hygiene | 2014

The Usefulness of Serum C-Reactive Protein and Total Bilirubin Levels for Distinguishing Between Dengue Fever and Malaria in Returned Travelers

Satoshi Kutsuna; Kayoko Hayakawa; Yasuyuki Kato; Yoshihiro Fujiya; Momoko Mawatari; Nozomi Takeshita; Shuzo Kanagawa; Norio Ohmagari

The clinical manifestations of dengue fever (DF) and malaria are similar. Specific diagnostic tests are not always available. A retrospective study to compare the laboratory results of malaria and DF was conducted at the National Center for Global Health and Medicine in Japan from January of 2005 to March of 2013. Febrile returned travelers from overseas diagnosed with malaria or DF were included; 86 malaria and 85 DF cases were identified. C-reactive protein (CRP) and total bilirubin (T-bil) had high area under the receiver operating characteristic curves (> 0.9). A cutoff value of CRP > 2.4 mg/dL to predict malaria as opposed to DF had a sensitivity of 91.9% (95% confidence interval [95% CI] = 83.9-96.7%) and specificity of 90.6% (95% CI = 82.3-95.8%). A cutoff value of T-bil > 0.9 mg/dL to predict malaria as opposed to DF had a sensitivity of 73.8% (95% CI = 62.7-83%) and a specificity of 95.1% (95% CI = 88-98.6%). CRP and T-bil are useful to distinguish between DF and malaria in returned travelers.


Journal of Infection and Chemotherapy | 2015

Travel-related leptospirosis in Japan: a report on a series of five imported cases diagnosed at the National Center for Global Health and Medicine.

Satoshi Kutsuna; Yasuyuki Kato; Nobuo Koizumi; Kei Yamamoto; Yoshihiro Fujiya; Momoko Mawatari; Nozomi Takeshita; Kayoko Hayakawa; Shuzo Kanagawa; Norio Ohmagari

Leptospirosis is one of the most common travel-related infections. We report 5 cases of travel-related leptospirosis who presented at our clinic between January 2008 and December 2013. Patients were included in the study if they presented with a clinical profile that was compatible with the disease within 21 days of their return from traveling, which were laboratory-diagnosed as leptospirosis by blood culture, rise in antibody titers in paired sera using the microscopic agglutination test (MAT), and/or DNA detection using flaB-nested PCR. Five leptospirosis cases were evaluated, all of which contracted the disease after exposure to fresh water in Southeast Asian countries. All of the cases had fevers, headaches, conjunctival injections, and relative bradycardia. The pertinent laboratory findings included elevated C-reactive protein levels, elevated creatinine levels, and sterile pyuria. All 5 cases had serum MAT titers that increased by ≥ 4 times in the interval between specimens taken during the acute phase and those taken during the convalescence phase, and leptospiral DNA was detected in plasma and/or urine specimens in 4 cases. Leptospira interrogans was isolated from one patients blood sample. Patients were treated with penicillin G, minocycline, or doxycycline. One case was cured without antibiotics. A diagnosis of leptospirosis should be considered for febrile travelers who return from Southeast Asian countries to Japan after being exposed to freshwater while traveling.


JMM Case Reports | 2016

Successful treatment of recurrent Helicobacter fennelliae bacteraemia by selective digestive decontamination with kanamycin in a lung cancer patient receiving chemotherapy

Yoshihiro Fujiya; Maki Nagamatsu; Junko Tomida; Yoshiaki Kawamura; Kei Yamamoto; Momoko Mawatari; Satoshi Kutsuna; Nozomi Takeshita; Kayoko Hayakawa; Shuzo Kanagawa; Kazuhisa Mezaki; Masao Hashimoto; Satoru Ishii; Norio Ohmagari

Introduction: Helicobacter fennelliae is an enterohepatic Helicobacter species causing bacteraemia in immunocompromised hosts. Only a few cases of recurrent H. fennelliae bacteraemia have been reported in Japan and there are no guidelines regarding antimicrobial treatment for H. fennelliae infection. Case presentation: H. fennelliae bacteraemia was observed in a patient receiving platinum-based chemotherapy for lung cancer. To prevent recurrence, the patient received antibiotic therapy with cefepime, amoxicillin and doxycycline for 6 weeks, which is similar to the therapy for Helicobacter cinaedi bacteraemia. Bacteraemia recurred despite the long-term antibiotic therapy. We hypothesized that the H. fennelliae bacteraemia originated from endogenous infection in the intestinal tract due to the long-term damage of the enteric mucosa by platinum-based drugs and performed selective digestive decontamination (SDD) with kanamycin. Bacteraemia did not recur after SDD. Conclusion: Our observations indicate that clinicians should be aware of possible recurrent H. fennelliae bacteraemia, which could be effectively prevented by SDD with kanamycin.


Journal of Travel Medicine | 2015

Imported Flood-Related Leptospirosis From Palau: Awareness of Risk Factors Leads to Early Treatment

Takashi Matono; Satoshi Kutsuna; Nobuo Koizumi; Yoshihiro Fujiya; Nozomi Takeshita; Kayoko Hayakawa; Shuzo Kanagawa; Yasuyuki Kato; Norio Ohmagari

We describe two Japanese travelers with leptospirosis who visited Palau. Both travelers swam in Ngardmau Falls, which was flooded for two days after typhoon Phanfone. The diagnoses were confirmed by microscopic agglutination test or polymerase chain reaction. This is the first report of leptospirosis in travelers who returned from Palau. It should be noted that choosing the appropriate test to biologically confirm leptospirosis was highly time-dependent. Awareness of the risk factors for leptospirosis, mainly that of the exposure to contaminated fresh water after a flooding, would lead to an early and appropriate treatment before the confirmed diagnosis.

Collaboration


Dive into the Yoshihiro Fujiya's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maki Nagamatsu

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Takashi Matono

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Tomohiko Takasaki

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Harumi Gomi

Jichi Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge